Russell Abberley
ABPI has appointed Russell Abberley as President-elect
Read More
Tag: ABPI
Russell Abberley
ABPI has appointed Russell Abberley as Acting President
Read More
NHS medicines access in jeopardy says ABPI
Review raises concerns about approach taken by the DHSC regarding changes to Statutory Scheme
Read More
ABPI reacts to new vital vaccination report
New HSCC document deems the UK’s vaccination position to be at risk
Read More
ABPI’s Patient Advisory Council boosted by new leaders
Five vital new appointments made to regulator’s insight, perspective and advice group
Read More
ABPI responds to rebooted MHRA clinical trials framework
Measures include a requirement to publicly register studies and share results among research participants
Read More
New ABPI proposals provide NHS and industry impetus
Pharma’s offer includes a yearly £1bn boost to the NHS and a new investment facility
Read More
Medicines policy may be halting Government’s drive for growth
Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023
Read More
Moderna becomes latest company to join the ABPI
Company becomes the latest member of the ABPI and galvanises the company’s UK connections
Read More
Association of the British Pharmaceutical Industry lays down new antibiotics mission
The challenge of resistant infections will require new antibiotics according to the ABPI
Read More
NHS patients missing out on new medicines that could extend lives
Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out
Read More
Highest ever number of HCPs named on Disclosure UK, says ABPI
Data also shows pharma companies worked with fewer HCPS and HCOs in 2020 compared to 2019
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
